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Abstract:  
Preterm birth, the leading cause of death in children under five, may be caused by 
inflammation triggered by ascending vaginal infection. About two million cervical cerclages 
are performed annually to prevent preterm birth. The procedure is thought to provide 
structural support and maintain the endocervical mucus plug as a barrier to ascending 
infection. Two types of suture material are used for cerclage: monofilament or multifilament 
braided. Braided sutures are most frequently used, though no evidence exists to favor them 
over monofilament sutures. In this study we assessed birth outcomes in a retrospective cohort 
of 678 women receiving cervical cerclage in 5 UK university hospitals and showed that 
braided cerclage was associated with increased intrauterine death (15% v 5%, P = 0.0001) 
and preterm birth (28% v 17%, P = 0.0006) compared to monofilament suture. To understand 
the potential underlying mechanism, we performed a prospective, longitudinal study of the 
vaginal microbiome in women at risk of preterm birth because of short cervical length (≤25 
mm) who received braided (n=25) or monofilament (n=24) cerclage under otherwise 
comparable circumstances. Braided suture induced a persistent shift towards vaginal 
microbiome dysbiosis characterized by reduced Lactobacillus spp. and enrichment of 
pathobionts. Vaginal dysbiosis was associated with inflammatory cytokine and interstitial 
collagenase excretion into cervicovaginal fluid and premature cervical remodeling. 
Monofilament suture had comparatively minimal impact upon the vaginal microbiome and its 
interactions with the host. These data provide in vivo evidence that a dynamic shift of the 
human vaginal microbiome toward dysbiosis correlates with preterm birth. 
  
Main Text: 
Introduction 
Each year, preterm birth (PTB, defined as delivery before 37 weeks of gestation) causes over 
one million deaths worldwide (1). Although preterm birth has multiple etiologies, infection is 
thought to be a causal mechanism in up to 50% of cases (2). It has been postulated that 
microbiota may spread hematogenously (3), or ascend from the vagina along mucosal 
surfaces. During a healthy pregnancy, the uterus and fetus are protected from ascending 
infection from the vagina by the cervix, which acts as a functional and physical barrier to 
bacteria and pathogens (4). In the vagina, Lactobacillus spp. stability and dominance are 
central to reproductive health. Pregnancy induces a shift in the vaginal microbiome from a 
temporally dynamic community structure in non-pregnant women (5) towards stable, 
Lactobacillus spp. dominance that inhibits growth of pathobionts (6, 7). The vaginal 
microbiome at delivery also acts as an important source of pioneering microbiota for the 
neonatal gut microbiome, thus implicating it in long-term health outcomes (8, 9). An 
association between vaginal dysbiosis during pregnancy, characterized by reduced quantities 
of Lactobacillus spp., and preterm birth has long been recognized (2, 10); women diagnosed 
with bacterial vaginosis have a 2- and 6-fold increased risk of preterm birth and late 
miscarriage, respectively (10). Recent analyses of the vaginal microbiome in pregnancy using 
culture-independent methods lend further support to associate vaginal dysbiosis and preterm 
birth (11). 
Cervical cerclage (12, 13) and progesterone supplementation (14) are the only widely used 
clinical strategies for the prevention of preterm birth, with an estimated two million cerclage 
procedures performed annually (15). Cervical cerclage reduces the risk of preterm birth by 
approximately 20% in women with a history of spontaneous preterm birth and/or a short 
cervical length (16, 17), and its use in these circumstances is recommended by both the 
American and the UK Royal College of Obstetricians and Gynecologists (12, 13). Its 
mechanisms of action are uncertain, but it is thought to provide mechanical support to a 
weakened cervix (18) as well as to support the cervical mucosal plug as a barrier to ascending 
infection (4). However, cervical cerclage is associated with increased risk of infection (17, 
19). The procedure involves placing a purse-string stitch around the cervix with or without a 
dissection of the bladder away from the cervix although there is no evidence for a benefit of 
bladder dissection (20). Two different suture materials, braided or monofilament, are used for 
the procedure, with braided preferred by 80% of surgeons without an evidence base (21, 22). 
Braided suture is composed of non-absorbable polyester ethylene terephthalate fibers braided 
together to form a 5 mm wide mesh tape. The tape is characteristically high in tensile strength 
and is thought to provide a secure structural support to a weakened cervix because of its high 
coefficient of friction (18). Monofilament sutures are made of a single strand of non-
absorbable polyamide polymer and because of their simple structure, they  provide less 
mechanical resistance when passed through tissue. As a result, they have a tendency to slip 
and therefore require a greater number of throws to secure the knot than a braided suture (18), 
which is why braided suture is usually preferred. 
 
However, an association between braided suture use and increased risk of infection in other 
disciplines (23, 24) has informed the hypothesis that pregnancy outcome after cervical 
cerclage may be influenced by suture material (15). Aiming to assess the impact of cerclage 
suture on vaginal microbiota, we hypothesized that the braided suture material promotes 
pathobiont colonization of the vagina, resulting in activation of inflammatory parturition 
pathways and premature cervical ripening. In this study we have undertaken a retrospective 
analysis of pregnancy outcomes in women receiving a clinically indicated cervical cerclage 
over a ten-year period across five university hospitals in England (UK). After this, a 
prospective cohort of women at risk of preterm birth were randomized to either braided or 
monofilament suture material. Longitudinal profiling of their vaginal microbiome in the 
context of cerclage insertion was undertaken using 16S rRNA gene sequencing. Cytokine 
expression profiling of matched cervico-vaginal fluid samples and cervical vascular 
assessment by 4-D ultrasound were concurrently performed as measures of physiological 
responses to cerclage insertion and changing microbial composition. 
 
  
1 Results  
Retrospective assessment of suture materials’ effects on pregnancy outcomes 
A total of 671 women receiving cervical cerclage during pregnancy were identified from five 
UK university hospitals within a 10-year period. Of these, 327 (49%) received a braided 
suture material and 344 (51%) received monofilament suture for their cervical cerclage. In 
women receiving a braided cerclage, higher rates of non-viable births (delivery <24 weeks or 
intrauterine death) were observed compared to those receiving the monofilament alternative 
(15% vs 5% respectively; P < 0.0001, Fig 1A). Increased rates of preterm birth (24-37 weeks 
gestation) were also observed in women receiving braided cerclage (28% braided vs 17% 
monofilament; P < 0.0001, Fisher’s exact test, Fig 1A). Comparison of available 
demographics demonstrated that consistent with known clinical practice (21, 22), preference 
of suture material varied across hospital sites (Table S1). Linear mixed effects modeling 
excluding hospital location, which is linked to choice of suture material, demonstrated that 
although history of a previous preterm birth was a significant contributor to non-viable births, 
braided suture was the primary driver of the observed outcome independent of potential 
confounders including maternal age, ethnicity, and parity (Fig. S1) but not hospital location. 
The effect of previous preterm birth was lost when hospital location was included in the 
model (Table S2). In both analyses, suture material was the major variable influencing the 
risk of preterm birth independent of maternal age, ethnicity, parity, and history of a previous 
preterm birth.  
 
Data on gestational age at cerclage insertion and corresponding cervical length were available 
for women receiving an ultrasound-indicated cerclage (for CL ≤β5 mm). Distribution of 
cervical length was comparable among monofilament and braided groups (P = 0.2; Mann-
Whitney, Table S1), and as would be expected, a shorter cervix significantly contributed to 
the risk of adverse outcome (P = 0.019). A sub-analysis using linear mixed effects regression 
models demonstrated that suture material remained a significant contributing factor for both 
preterm birth (P = 0.00002) and non-viable pregnancy (P = 0.006) among ultrasound-
indicated cerclages after adjusting for potential confounders including gestational age at 
insertion (Table S2).  
 
Baseline characteristics of the prospective study subjects  
Women who were attending prematurity surveillance clinic after a history of preterm birth 
and were sonographically identified as having a short cervix (≤25 mm) were prospectively 
recruited and randomized to receive a cerclage using either braided Mersilene (n=25) or 
monofilament Ethilon (n=24) suture material. Demographics among suture material groups, 
including gestation and cervical length at cerclage insertion were comparable (Table 1).  
 
Suture material impact on the vaginal microbiome 
The data set consisted of 2,792,842 high quality gene sequences, with a mean sequence read 
count of 13,825 per sample (range 689 to 1,396,421). Using bacterial genera sequence data, 
samples were classified according to their vaginal bacterial communities as normal (>90% 
Lactobacillus spp.), intermediate (30-90% Lactobacillus spp.), or dysbiotic (<30% 
Lactobacillus spp.) (Fig. 1B and Table S3). Before cerclage insertion, prevalence of 
intermediate and dysbiotic microbiomes in monofilament and braided patient groups was 
similar (16.7% v 17.3%, P = 0.7, Fig. 1C). These were higher than the rates of dysbiosis 
observed in the background low-risk pregnant population at the same gestational age not 
requiring intervention who had normal pregnancy outcomes (6%, Fisher’s exact, P = 0.03) 
(6). 
Insertion of the braided cerclage caused a dramatic shift towards dysbiosis at 4 weeks after 
the procedure, which persisted until the final follow up timepoint, at 16 weeks after cerclage 
insertion (P = 0.008, ANOVA, Fig. 1C, Table S4). When assessed at the species level (Fig. 
S3, Fig. S4, and Tables S4 and S5), braided cerclage insertion was associated with an 
increasing proportion of women with community state type (CST) IV, characterized by 
reduced numbers of Lactobacillus spp. and increased diversity of anaerobic bacteria (6, 25). 
Before the insertion of braided cerclage, 13% were classified as CST IV, increasing to 45% at 
4 weeks and 50% at 16 weeks after cerclage (P = 0.02, Fig. S4A, Table S4). In contrast, 
microbial disruption was not observed in women receiving monofilament cerclage, who 
instead demonstrated maintenance of high Lactobacillus spp. abundance (CSTs I, II, III, and 
V) and stability throughout longitudinal sampling (P = 0.9; Fig. S4A and Table S4). To 
identify degrees of dysbiosis that were not identified by CST classification, we also 
undertook alternate species level classification based upon dominance of vaginal bacterial 
communities by Lactobacillus species associated with stability and health, L. iners 
dominance associated more frequently with transition to dysbiosis, as well as intermediate 
and severe dysbiosis (26). Although L. iners has previously been observed as an intermediary 
towards dysbiosis, there was no significant change in L. iners abundance in association with 
insertion of a monofilament or braided suture material (Fig. S4B and Table S5). 
 
An in vitro adhesion assay showed that braided suture cultured with the vaginal commensal 
L. jensenii or the pathobiont E. coli resulted in a 16- and 20-fold greater bacterial load 
adherence per unit length (cm), respectively, compared to monofilament suture (P = 0.03 and 
P = 0.0003, respectively, Student’s t-test; Fig. S5).  
 
To identify bacteria specifically associated with braided suture insertion, we performed linear 
discriminant analysis with effect size (LEfSe)(27) on the 16S rRNA sequence data collected 
before and 4 weeks after the procedure. Although no differences were identified between 
patient groups before insertion, braided cerclage resulted in enriched numbers of Gram-
negative bacteria at 4 weeks (Fig. 2A and B). This correlated with a 5-fold increase in the 
number of dysbiotic samples collected after braided cerclage insertion compared to 
monofilament cerclage (P = 0.04, ANOVA; Fig. 2C). Use of braided cerclage was 
characterized by increased numbers of bacteria associated with bacterial vaginosis, including 
species of Prevotella (P = 0.02), Finegoldia (P = 0.02), and Dialister (P = 0.04), and reduced 
Lactobacillus spp. (Fig. 2A, B and Fig. S6). Targeted qPCR suggested that insertion of 
braided suture was associated with an increase in mean copy numbers of both A. vaginae 
(594,326 before cerclage v 5,081,000 after cerclage; P = 0.07) and G. vaginalis (961,805 
before cerclage v 10,170,000 after cerclage; P = 0.05; Fig. S7, Table S6). In contrast, no 
change in the amount of G. vaginalis or A. vaginae was detected after monofilament cerclage. 
Consistent with these observations, indices of bacterial community richness (Fig. 2D) and 
alpha-diversity (Fig. 2E) were increased in samples collected after braided suture compared 
to monofilament, with the greatest differences observed at 16 weeks after cerclage (P = 0.02; 
ANOVA, Bonferroni multiple comparison).  
 
Inflammatory response to cerclage insertion  
Insertion of braided, but not monofilament cerclage, increased the release of inflammatory 
cytokines into cervico-vaginal fluid, including IL-1ȕ, IL-6, IL-8, TNFα, and MMP-1 (Fig. 
3A-F). No change was detected in anti-inflammatory cytokines IL-4 (Fig. 3G) IL-2, or IL-10 
(Table S7). We observed a strong association between severe dysbiosis (<30% Lactobacillus 
spp.) and increased cervico-vaginal fluid concentrations of pro-inflammatory cytokines 
ICAM-1, IL-1ȕ, IL-6, MMP-1, MCP-1, TNF-α, GM-CSF, and IFN-Ȗ, as well as the anti-
inflammatory cytokine IL-10 when compared to women harboring Lactobacillus spp. 
dominated microbiomes (Fig. 3H).  
Impact on cervical vasculature after cerclage  
We constructed three-dimensional cervical vascular trees from ultrasound data and assessed 
the indices of cervical vasculature (Vascularity index, VI) (28) for morphological differences 
in the cervix according to suture material. The vascularity was not significantly different 
between the two groups before cerclage insertion (Fig. 4A). Braided cerclage was strongly 
associated with increased cervical vascularization 4 weeks after the procedure, and this 
relationship persisted until 16 weeks after insertion (P = 0.0003; ANOVA, Bonferroni 
multiple comparison, Fig. 4A). A positive correlation of cervical vascularity with both the 
number of bacterial species (Fig. 4B, R2 = 0.09, P = 0.002) and alpha diversity (Fig. 4C, R2 = 
0.14, P = 0.001) was observed in women receiving a braided cerclage. No relationship 
between monofilament suture, cervical vascularization, and indices of microbial diversity or 
richness was observed. 
  
Discussion  
Braided suture material is commonly used in preference to monofilament for cervical 
cerclage (21), because it is assumed that braided suture provides a more secure cerclage that 
is less likely to slip or tear the cervix (18), however this is not evidence based. Here we show 
that use of braided suture material is associated with an increased risk of preterm birth and 
non-viable pregnancy, although this will need to be confirmed in a prospective randomized 
study. Braided cervical cerclage induces vaginal dysbiosis, increases excretion of 
inflammatory cytokines into the cervico-vaginal fluid, and induces premature cervical 
vascular remodeling. In contrast, monofilament suture has minimal impact upon the vaginal 
microbiome and inflammatory pathways associated with premature onset of parturition. 
These findings have clinical relevance for cerclage procedures in pregnancy and wider 
implications for braided suture use in other surgical procedures, particularly in potentially 
contaminated sites. Based upon an approximated two million cervical cerclages per annum 
(15), 80% of which are performed using braided suture (21), we estimate that a global shift to 
monofilament suture use for cervical cerclage would prevent 170,000 preterm births (number 
needed to treat NNT 9.4; 95% CI 5.9 to 22.6) and 172,000 fetal losses (NNT, 9.3; 95% CI 6.6 
to 16.0) per annum world-wide.  
Although cervical cerclage is effective in preventing preterm birth in singleton pregnancies 
with a previous preterm birth (17, 29), our data show that braided cervical cerclage increases 
vaginal dysbiosis and inflammation, and likely accounts for the doubled risk of puerperal 
sepsis (19) with no improvement in neonatal outcome (17) after cerclage insertion. Moreover, 
increasing evidence suggests that the braided cerclage is of no benefit, and may even be 
detrimental in other groups that are at high risk for preterm birth, such as multiple 
pregnancies (30) and women with a shortened cervix after excisional treatment for cervical 
intra-epithelial neoplasia (31-34). The role of suture material in cerclage efficacy has largely 
been neglected, with studies rarely detailing the suture material used for the procedure (35). 
To date, only one randomized controlled trial has been conducted to examine the impact of 
suture material on pregnancy outcomes, but this study was limited to the comparison of two 
braided materials, and no differences in preterm birth rates were observed (22). Re-evaluation 
of existing literature on cervical cerclage use in pregnancy for the prevention of preterm birth 
is required in light of our findings.  
Our study is limited by the retrospective nature of the comparisons of pregnancy outcome. 
However, the cohort size is large, and preterm delivery rates for each suture material were 
similar at each of the five centers. The size of the prospective study was limited by 
practicalities and cost of intensive multiple investigations; however, the experimental data 
provide supporting evidence for the mechanism of poorer outcomes in patients treated with 
braided suture cerclage. Analysis of the vaginal microbiome was undertaken using three 
alternate approaches. We primarily used a genera based classification of normal, intermediate 
and severe dysbiosis, which demonstrated that the principal effect of braided cerclage is to 
reduce lactobacillus numbers and induce vaginal dysbiosis. We next classified samples at 
species level into 5 previously described CSTs, however, this analysis was limited to the 
consideration of only one dysbiotic group. Therefore an alternate species level classification 
considering two levels of dysbiosis (intermediate and severe) was also undertaken.  
The inherent capacity of braided suture material to facilitate bacterial growth has been 
previously described in other surgical arenas (36, 37); however, our in vivo and in vitro data 
provide evidence for preferential pathobiont colonization over commensal vaginal species 
that are important for reproductive health outcomes. Vaginal dysbiosis associated with 
braided cerclage insertion was characterized by reduced Lactobacillus species and increased 
diversity and enrichment of bacteria associated with poor pregnancy outcomes, including 
Peptoniphilus harei (38), species of Bacteriodes (38, 39), Prevotella (40), and Clostridium 
(41). However, it is recognized that sequencing of specific hypervariable regions of the 16S 
rRNA gene can result in underrepresentation of key vaginal microbiota such as G. vaginalis, 
which together with A. vaginae is characteristic of bacterial vaginosis (BV) (42, 43), a 
condition associated with adverse reproductive health outcomes including pelvic 
inflammatory disease (44), HIV transmission (45), and preterm birth(46). Using targeted 
qPCR, we showed that dysbiosis associated with braided cerclage insertion may involve 
increased abundance of G. vaginalis. The virulence of G. vaginalis is thought to relate to its 
biofilm-producing capacity and adherence to vaginal epithelial cells (42, 47). It is possible 
that such characteristics may promote biofilm formation on the surface of cerclage suture 
material, and this should be examined in future studies. Other bacteria clinically associated 
with adverse pregnancy outcome include S. agalactiae (Group B streptococcus) and E. coli. 
However, we did not observe any changes in the amounts of S. agalactiae. E. coli was not 
detected in our data set, but this may reflect a limitation of the primer set used for 16S rRNA 
sequencing (48, 49). 
Increased bacterial diversity in the vagina corresponded to the induction of a pro-
inflammatory cytokine profile in cervico-vaginal fluid involving known mediators of cervical 
vascular remodeling, including IL-1ȕ, IL-6, IL-8, and TNFα (50-52). Concentrations of 
MMP-1, a matrix metalloproteinase central to collagenous remodeling preceding preterm 
birth (53, 54), were also increased after insertion of braided cerclage. Increased cervical 
vascularity occurs before term parturition (28, 55), and an association between increased 
cytokine excretion and cervical angiogenesis, vasodilation, and vascular permeability has 
been previously described (56). Consistent with a role in untimely cervical remodeling 
preceding preterm birth, increased cervical vascularity was observed as early as 4 weeks after 
insertion in women receiving a braided cerclage. Our study therefore provides a human 
model for understanding how pregnant host-vaginal microbial interactions may underpin poor 
pregnancy outcomes. Cerclage-induced inflammation resulting in premature weakening of 
the cervix could also provide a mechanism for high rates of intrauterine death in women 
receiving a braided cerclage, because in-utero exposure of the fetus to elevated 
concentrations of circulating pro-inflammatory cytokines is known to associate with fetal 
brain injury (57, 58) and stillbirth (59-61).  
In summary, our data provide evidence that cervical cerclage using braided suture associates 
with increased rates of preterm birth and non-viable pregnancy. Promotion of vaginal 
bacterial dysbiosis after insertion of braided suture material likely contributes to these 
adverse pregnancy outcomes through activation of local tissue inflammation and premature 
cervical remodeling. Because monofilament suture has minimal impact on the host 
microbiome or inflammation in pregnancy and associates with improved pregnancy outcome, 
we advocate its use for cervical cerclage. Further clinical trials addressing the impact of 
cerclage suture material, powered to assess outcomes of preterm birth, neonatal morbidity, 
and mortality, are therefore urgently required. 
  
Materials and Methods 
The study was approved by NHS National Research Ethics Service (NRES) Committee 
London - City & East (REC 12/LO/2003), and all participants provided written informed 
consent.  
Study design 
We initially performed a retrospective data collection to assess outcomes of cervical 
cerclages in singleton pregnancies considered at risk of preterm birth over a ten-year period 
between January 2003 and 2013 across five UK hospitals in London, Cambridge, and 
Birmingham. Cases were identified from operating theatre logs, and all case notes were 
reviewed where possible. Details regarding cerclage suture insertion, suture material used, 
outcomes of preterm birth (between 16+0 and 36+6 weeks’ gestation), and non-viable birth 
(still birth or miscarriage >16+0 weeks’ gestation) were collected. Other metadata collected 
included maternal age, parity, previous spontaneous preterm birth / midtrimester miscarriage, 
indication for cerclage (ultrasound indicated or elective), and cervical length at cerclage 
insertion.  
After this, we prospectively recruited pregnant women at risk of preterm birth with 
sonographic indications for cervical cerclage at preterm surveillance clinics from January 
2013 until August 2014 at a single London site (Queen Charlotte’s and Chelsea Hospital). 
Inclusion criteria were pregnant women with history of spontaneous preterm birth (<37+0 
weeks) and a cervical length (CL) measurement below the 10th centile (≤β5 mm) on 
transvaginal scan at ≤ βγ+6 weeks’ gestation in the index pregnancy. A normally distributed 
cervical length range not associated with preterm birth risk is typically 35 mm ± 8.3 mm 
(mean ± SD) (62).   
Exclusion criteria included multiple pregnancy, previous iatrogenic preterm births, HIV 
positive status, and sexual intercourse or vaginal bleeding in the preceding 48 hours. Eligible 
women were randomized to either braided Mersilene (n=25) or monofilament Ethilon (n=24) 
cerclage suture material. The same obstetrician performed the procedure using the 
MacDonald technique (63). Participants were recruited before cerclage insertion and 
followed up longitudinally at 4, 8, 12, and 16 weeks after insertion. At each time point, 
cervico-vaginal fluid was sampled from the posterior fornix under direct visualization using 2 
swabs for later 16s rRNA gene sequencing and cytokine analysis: a BBL CultureSwab MaxV 
Liquid Amies swab (Becton, Dickinson and Company) and a Transwab MW170 with rayon 
bud type (Medical Wire & Equipment), respectively. Both swabs were immediately placed on 
ice and snap frozen at -80°C. A transvaginal ultrasound scan was then immediately 
performed to assess cervical vascularization in the dorsal lithotomy position with an empty 
bladder, taking care to avoid undue pressure on the cervix. 
DNA extraction and 16S rRNA sequencing  
DNA extraction from the BBL CultureSwab was performed as previously described (6). 
Integrity of the extracted bacterial DNA was confirmed by PCR amplification using universal 
forward and reverse primers (6). The V1-V3 hypervariable regions of 16S rRNA genes were 
amplified for sequencing using a forward and reverse fusion primer. The forward primer was 
constructed with (5′-γ′) the Illumina i5 adapter 
(AATGATACGGCGACCACCGAGATCTACAC), an 8 bp barcode, a primer pad (forward: 
TATGGTAATT), and the 28F-GAGTTTGATCNTGGCTCAG primer (64). The reverse 
fusion primer consisted of (5′-γ′) the Illumina i7 adapter 
(CAAGCAGAAGACGGCATACGAGAT), an 8 bp barcode, a primer pad (reverse: 
AGTCAGTCAG), and the reverse primer (519R-GTNTTACNGCGGCKGCTG). Sequencing 
was performed on an Illumina MiSeq platform (Illumina, Inc.) at Research and Testing 
Laboratory (Lubbock, TX, USA). Resulting sequence reads were analyzed using the MiSeq 
SOP Pipeline of the Mothur package (65), which is designed to analyze a multiplexed set of 
samples. Sequence alignment was performed using the Silva bacterial database (www.arb-
silva.de/), and classification of sequences was undertaken using the RDP database reference 
sequence files and the Wang method (66). OTU taxonomies (phylum to genus) were 
determined using the RDP MultiClassifier script. Species level taxonomies were determined 
using USEARCH with 16S rRNA gene sequences from the cultured representatives from the 
RDP database (67). Sequence alignment data describing the capacity of the V1-V3 amplicons 
to discriminate Lactobacillus spp. are provided in Table S8 and Fig. S8. Data were re-
sampled and normalized to the lowest read count in Mothur (n=689).  
Quantitative PCR 
Targeted quantitative PCR was carried out to detecct 16S rRNA genes from Atopobium 
vaginae and Gardnerella vaginalis. The assays were SYBR green based and performed on 
Applied Biosystem’s StepOnePlus. PCR reaction mixes are as follows: 1x SYBR Green 
Jumpstart Taq Ready Mix (Sigma-Aldrich), 5 μl of bacterial DNA isolated from the vaginal 
swabs, and 0.8 µM final concentration of forward and reverse primers. Oligonucleotide 
primers used for A. vaginae were: forward- 5’-TAGGCGGTTTGTTAGGTCAGGA-γ’; 
reverse- 5’-CCTACCAGACTCAAGCCTGC-γ’ (68) and for G. vaginalis; forward- 5’-
GGAAACGGGTGGTAATGCTGG-γ’; reverse- 5’-CGAAGCCTAGGTGGGCCATT-γ’) 
(69). Thermocycle profile was 95ºC for 2 minutes, followed by 40 cycles at 95ºC for 15 sec 
and 65 ºC for 1 min. For both assays, vaginal samples and corresponding standards (A. 
vaginae and G. vaginalis DNA) were run in duplicates, and mean numbers were used to 
calculate 16S rRNA gene copies per 5 µl of vaginal DNA.  
In vitro adhesion assay  
Propensity of bacteria to adhere to braided and monofilament suture material was assessed 
using an in vitro adhesion assay (70). Briefly, 1 cm segments of sterile braided Mersilene or 
monofilament Ethilon were prepared with a sterile blade and tweezers. Suture fragments were 
placed into a sterile screw-capped tube and incubated with 1 ml of 100% ethanol for 1 hour at 
room temperature. Fragments were washed 3x using 1 mL of sterile water before inoculation 
with E. coli (Nissle 1917) using LB broth and LB plates or Lactobacillus jensenii (Cultech 
Ltd.) using MRS broth and MRS plates. 
For each bacterial isolate we tested the following groups: inoculated Mersilene thread 
fragments (n=3), uninoculated Mersilene thread fragment (sterility control, n=1), inoculated 
Ethilon thread fragments (n=3), uninoculated Ethilon thread fragment (sterility control, n=1). 
An overnight bacterial culture was centrifuged at 3,000 x g for 10 min, and the supernatant 
was discarded. Cell pellets were resuspended in fresh broth to a final concentration of 107 
CFU/mL and 1 mL of this cell suspension was added to each of the suture fragments. For 
sterility controls, 1 mL of sterile broth was added to an uninoculated Mersilene and Ethilon 
thread fragment. Suture thread fragments were incubated at 37ºC for 24 h before being 
washed 3x with sterile PBS and transferred into tubes containing 1 ml of sterile PBS. Each 
tube was vortexed 3 x for 30 seconds to detach bacterial cells. The cell suspension was 
vigorously passed through a 25G needle 10 times to break up cell clumps. Aliquots of 100 µL 
were collected from the cell suspension and used for colony counts on LB or MRS agar 
plates. After incubation, we used plate colony counts to calculate the CFU/mL of cell 
suspension. Thread fragment length was accurately measured after cell suspension plating to 
calculate CFU/cm. 
Cytokine Analysis 
The transwab cervico-vaginal fluid samples were thawed on ice and resuspended in 350 µL 
of phosphate-buffered saline solution with protease inhibitor (5 μl/ml; Sigma Aldrich). The 
suspension was centrifuged at 3000 x g for 2 min and the supernatant collected into a new 
microcentrifuge tube before repeating the centrifugation step to ensure removal of any 
cellular debris. Cell-free supernatants were analyzed by Human Magnetic Luminex Screen 
Assay (15-plex) (Luminex Corporation) with a Bioplex 200 system (Biorad Laboratories 
Ltd.). Analyte-specific Luminex Screening Assays were performed for 15 analytes: 
interleukin (IL)-1ȕ, IL-2, IL-4, IL-6, IL-8, IL-10, granulocyte colony-stimulating factor (G-
CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), monocyte chemotactic 
protein (MCP)-1, tumor necrosis factor (TNF)-α, interferon (IFN)-Ȗ, regulated on activation 
normal T expressed and secreted/chemokine ligand 5 (RANTES/CCL5), vascular endothelial 
growth factor (VEGF), intercellular adhesion molecule 1 (ICAM-1), and matrix 
metalloproteinase 1 (MMP-1). Analytes were selected according to evidence of involvement 
in inflammatory change related to preterm birth, cervical ripening, and angiogenesis. Samples 
were analyzed on 96-well plates at two dilutions (1:1 and 1:50) optimized for detection of 
analytes within the range of the standards as specified by Luminex Human premixed analyte 
kit.  
Cervical vascularization assessment 
Voluson E ultrasound (GE Healthcare) in 3D/4D mode with medium persistence, high 
sensitivity, and normal line density was used for transvaginal cervical vascular assessment. A 
sagittal plane of volume acquisition, set at 90°, was analyzed using Virtual Organ Computer-
aided AnaLysis software program (VOCAL, GE Medical Systems) (28). The “histogram 
facility” of the software was used calculated the vascularization index (VI) within the defined 
volume.  
Statistical analysis  
Assessment of differences in outcomes of viability and preterm birth between cerclage suture 
material groups (braided versus monofilament) was performed using the Fisher exact test for 
categorical variables and Mann-Whitney for continuous variables. We used a linear mixed-
effects model incorporating suture material group, maternal age, parity, previous preterm 
birth, and hospital location as fixed effects and ethnicity (Asian, Black, or Caucasian) as a 
random effect to compare braided versus monofilament suture material for the two primary 
outcomes (viability and preterm birth). The contributions of fixed-effects terms (p-value and 
F statistics) were calculated using the analysis of variance (ANOVA) with Satterthwaite 
approximation for degrees of freedom. 
Examination of statistical differences between vaginal microbiota were performed at bacterial 
genera and species levels using the Statistical Analysis of Metagenomic Profiles (STAMP) 
software package (71). Ward linkage hierarchical clustering analysis (HCA) of bacterial 
genera was performed using a clustering density threshold of 0.75. Samples were classified 
according to the percentage of Lactobacillus spp. reads as a proportion of the total number of 
reads per sample into the following groups: normal (>90% Lactobacillus spp.), intermediate 
(30-90% Lactobacillus spp.), or dysbiotic (<30% Lactobacillus spp.). Bacterial species data 
were classified into community state types (CSTs) as described by Ravel et al (25): CST I (L. 
crispatus), CST II (L. gasseri), CST III (L. iners), CST IV (mixed bacterial species), and CST 
V (L. jensenii). To identify potential associations between suture material and differing 
degrees of dysbiosis, an alternative classification of the species data was performed, as 
described by Borgdorff et al (26) into communities characterized by healthy Lactobacillus 
spp. dominance, L. iners, or moderate or severe dysbiosis.  
The effects of suture material and time from cerclage insertion on bacterial genera, number of 
species observed and alpha diversity were assessed using One-way ANOVA, Kruskal-Wallis, 
and Dunn’s multiple comparisons where appropriate. 
Linear discriminant analysis (LDA) effect size (LEfSe) method (27) characterized 
differentially abundant taxonomic features of the two suture materials before and 4 weeks 
after cerclage insertion. An alpha value of 0.01 was used for factorial Kruskal-Wallis test 
between classes, and a threshold of 3.0 was used for logarithmic LDA score for 
discriminative features.  
The Wilcoxon signed rank test compared cytokine analyte concentrations before and 4 weeks 
after cerclage insertion. The Mann-Whitney test was used to test for differences among suture 
material types. Analyte expression was classified according to the corresponding 
microenvironments (Fig. 1C), and the Mann-Whitney test compared cytokine expression in 
the presence of a normal or dysbiotic microbiome. 
Cervical vascularization was compared according to suture material from the time of cerclage 
insertion and as a function of the corresponding bacterial classification, using Kruskal-Wallis 
and ANOVA multiple comparison analyses where appropriate. We used linear regression to 
assess for correlations between cervical vascularity, the number of observed species, and 
Shannon index of alpha diversity, according to suture material. 
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Figures:  
 
 
  
Figure 1. Braided suture material for cervical cerclage is associated with worse 
outcomes.  
(A) Retrospective comparison of 10 years of birth outcomes for women receiving a cerclage 
based on suture material (monofilament, n=344 vs braided, n= 337) revealed higher rates of 
non-viable births (delivery <24 weeks or intrauterine death) in women receiving a braided 
cerclage compared to a monofilament alternative (15% vs 5% respectively; P = 0.0001, 
Fisher’s exact test) and increased rates of preterm birth (24-37 weeks gestation) in women 
receiving braided cerclage (28% braided vs 17% monofilament; P = 0.0006, Fisher’s exact 
test) (see Table S3 for details). (B) Ward-linkage analysis of vaginal bacterial genera of 
cervical vaginal fluid samples (n=197) collected longitudinally before and after insertion of a 
monofilament (n=24) or braided (n=25) cervical cerclage permitted classification of vaginal 
bacterial communities into three groups: normal (>90% Lactobacillus abundance), 
intermediate (30-90% Lactobacillus abundance), or dysbiotic (<30% Lactobacillus 
abundance). (C) Braided cerclage was associated with a 5-fold increase in microbial 
dysbiosis within 4 weeks of insertion, which persistent until at least 16 weeks, whereas no 
change was observed in women receiving a monofilament cerclage (P values = fishers exact 
before v after cerclage, and 2 way ANOVA: monofilament vs braided at comparable time 
points).   
  
  
Figure 2. Bacterial taxonomic groups discriminate between monofilament and braided 
cerclage. (A) Differentially abundant microbial clades and nodes according to suture material 
four weeks after insertion were identified using LEfSe analysis and presented as a cladogram. 
(B) Linear Discriminant Analysis (LDA) was used to estimate the effect size for each 
differentially abundant species. The vaginal microbiome of patients receiving a monofilament 
cerclage was enriched with bacilli, whereas those receiving a braided cerclage were 
comparatively enriched in Bacteroides spp., and Clostridia. (C) Relative abundance bar 
charts for individual samples highlight maintenance of Lactobacillus genus stability after 
insertion of monofilament cerclage (P = 0.9; ANOVA), in contrast to the decreased numbers 
after braided cerclage (P = 0.043; ANOVA) (P values = corrected two-sided Welch’s t-test 
for monofilament vs. braided). (D) Comparison of total number of bacterial species observed 
reveals an increase after braided cerclage compared to a monofilament cerclage. (E) Alpha 
diversity was increased at 16 weeks after braided cerclage insertion compared to 
monofilament. (*P values = corrected two-sided Welch’s t-test for monofilament vs. braided, 
#P values = ANOVA Bonferroni multiple comparison to before-cerclage samples). 
 
Figure 3. Braided suture induces cytokine release into the cervico-vaginal fluid. (A) 
Cytokines were detected using a multiplex assay before and 4 weeks after cerclage insertion. 
An increase in pro-inflammatory cytokines was detected in the cervico-vaginal fluid after 
braided cerclage (see Table S7 for details). Relative to the concentrations before cerclage, 
braided suture was associated with an increase in pro-inflammatory cytokines (B) IL-1ȕ, (C) 
IL-6, (D) IL-8, (E) TNF-α, and (F) MMP-1 but not (G) IL-4 (*P values = Wilcoxon signed 
rank test for cytokine concentration before and after cerclage). Similar changes were 
observed when the braided cerclage samples were compared for cytokine concentrations 4 
weeks after monofilament cerclage (#P values = Mann-Whitney for fold change 
monofilament vs. braided). (H) Mean cytokine profiles grouped by the corresponding 
microbial classification (normal, intermediate, and dysbiotic) revealed that dysbiosis is 
associated with increased expression of pro-inflammatory cytokines ICAM-1, IL-1ȕ, IL-6, 
MMP-1, MCP-1, TNF-α, GM-CSF, and IFN-Ȗ and anti-inflammatory IL-10, but not G-CSF, 
IL-8, VEGF, RANTES, IL-β or IL-4. (P value = Mann-Whitney for normal vs dysbiotic). 
 
   
Figure 4. Braided cerclage induces premature cervical vascularization. (A) Cervical 
vascularization index (VI), as assessed by transvaginal ultrasound, was greater in patients 
receiving braided cerclage compared to monofilament cerclage at 4, 8, 1β, and 16 weeks after 
insertion (*P value = Welches corrected t-test for monofilament vs braided, #P value =  
ANOVA, Bonferroni multiple comparison for before vs after cerclage). (B) Linear regression 
analyses demonstrated a positive correlation between VI and the number of species observed 
in braided (Rβ=0.09, P = 0.00β) but not monofilament (Rβ=0.001, P = 0.75) cerclages. (C) A 
similar relationship was observed between VI and alpha diversity index (braided: Rβ = 0.14, P 
= 0.001 and monofilament: Rβ=0.0β, P = 0.14), indicating an interplay between braided 
suture, increased cervical vascularity, and vaginal microbial dysbiosis. 
Tables 
Table 1. Patient characteristics for women randomized to receive monofilament and 
braided cervical cerclages 
BMI= body mass index; CL = cervical length (mm); GA = gestational age; w= weeks; SD=standard 
deviation 
 
 
Monofilament suture Braided suture Total population 
n (%) 24/49 (49%) 25/49 (51%) 49/49 
Age, Mean ±SD (range) years 32.8 ± 3.0 (27-39) 33.9 ± 3.8 (25-42) 33.5 ± 3.5  (25-42) 
BMI, Mean ±SD (range) 24.1 ± 4.2 (18-35) 26 ± 3.6 (21-36) 25.1 ± 4.5 (18-36) 
Ethnicity, n (%)    
Caucasian 16 (67%) 11 (44%) 27 (55%) 
Asian 2 (8%) 7 (28%) 9 (18%) 
Black 6 (25%) 7 (28%) 13 (27%) 
Parity, n (%) 
  
 
Para 0 12 (50%) 13 (52%) 25 (51%) 
Smoking, n (%) 1 (4%) 2 (8%) 3 (6%) 
Cerclage insertion 
  
 
GA at insertion, mean ±SD w 17+6 ± 2.8 18+1 ± 3 17+0 ± 2.9 
CL at insertion, mean ±SD mm 18 ± 5.1 19 ± 4.5 19  ± 5.3 
GA at delivery, n (%) 
  
 
<34+0 w 4/24 (16%) 0/25 (0%) 4 (8%) 
34+1-36+6 w 2/24 (8%) 8/25 (32%) 10 (20%) 
≥37+0 w 18/24 (75%) 17/25 (68%) 35 (71%) 
